|
Notice:
|
|
Suspension of shipments during Golden Week Holidays: From 30 April to 14 May, deadline 17 April.
|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
discarded
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
17919R-3 |
| Symbol |
CG17919 |
Full Name |
CG17919 |
| CG No |
CG17919 |
Old CG No |
CG17919 |
| Synonyms |
CG17919 |
| Accession No (Link to NCBI) |
NM_141387.2 |
| Inserted Chr. |
lll |
| Insertional Mutation |
|
| Phenotype induced by Act5C-GAL4 at 28 degrees |
semi-lethal |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Graca FA, Rai M, Hunt LC, Stephan A, Wang YD, Gordon B, Wang R, Quarato G, Xu B, Fan Y, Labelle M, Demontis F.
The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy.
Nat Commun (2022) 13(1) 2370
[
PubMed ID = 35501350
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD.
Zyxin links fat signaling to the hippo pathway.
PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgGCCGAACCAGTTGTTAAAGGT |
| Primer Seq. 3' |
aatctagaggtaccTTCTCCGAAAGTTGCTTGTGC |
| Predicted Fragment Size |
495 |
| IR fragment full Seq |
0001 GCCGAACCAG TTGTTAAAGG TCACGTACAG CAACAACCTG GTGGCCAAGG ATGGAGCNCG
0061 TGgaGCTAAC GCCCACCCAG GTTAAGGATC AGCCAGTCGT GGAGTGGGAC GCGCAGCCCG
0121 GGGAGTTCTA CACGCTCATT ATGACGGATC CCGATGCCCC CAGCCGAGCG GAGCCCAAGT
0181 TCCGCGAGTT CAAGCACTGG ATTCTGGCCA ACATCGCCGG CAACGACTTG GCAAGTGGTG
0241 AGCCCATCGC CGAGTACATT GGCTCCGGCC CGCCCCAGGG CACGGGTCTG CATCGCTACG
0301 TCTTCCTGCT GTACAAGCAG TCCGGCAAAC TTGAGTTCGA CGAGGAGCGC GTGAGCAAGA
0361 GATCCCGCAA GGATCGCCCC AAATTCAGTG CCGCCAAGTT TGCCATCAAT CACGAGTTGG
0421 GCAATCCCAT TGCTGGAACT TTCTACCAAG CCCAGTACGA CGACTATGTT CCAAAACTGC
0481 ACAAGCAACT TTCGGAGAA |
| in silico PCR Fragment |
0001 GCCGAACCAG TTGTTAAAGG TCACGTACAG CAACAACCTG GTGGCCAAGG ATGGA----G
0061 TGGAGCTAAC GCCCACCCAG GTTAAGGATC AGCCAGTCGT GGAGTGGGAC GCGCAGCCCG
0121 GGGAGTTCTA CACGCTCATT ATGACGGATC CCGATGCCCC CAGCCGAGCG GAGCCCAAGT
0181 TCCGCGAGTT CAAGCACTGG ATTCTGGCCA ACATCGCCGG CAACGACTTG GCAAGTGGTG
0241 AGCCCATCGC CGAGTACATT GGCTCCGGCC CGCCCCAGGG CACGGGTCTG CATCGCTACG
0301 TCTTCCTGCT GTACAAGCAG TCCGGCAAAC TTGAGTTCGA CGAGGAGCGC GTGAGCAAGA
0361 GATCCCGCAA GGATCGCCCC AAATTCAGTG CCGCCAAGTT TGCCATCAAT CACGAGTTGG
0421 GCAATCCCAT TGCTGGAACT TTCTACCAAG CCCAGTACGA CGACTATGTT CCAAAACTGC
0481 ACAAGCAACT TTCGGAGAA |
| Assemble Data |
17919R-3.IR_full 1 GCCGAACCAGTTGTTAAAGGTCACGTACAGCAACAACCTGGTGGCCAAGGATGGAGCNCG 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
17919R-3.in silico 1 GCCGAACCAGTTGTTAAAGGTCACGTACAGCAACAACCTGGTGGCCAAGGATGGA----G 60
17919R-3.IR_full 61 TGGAGCTAACGCCCACCCAGGTTAAGGATCAGCCAGTCGTGGAGTGGGACGCGCAGCCCG 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17919R-3.in silico 61 TGGAGCTAACGCCCACCCAGGTTAAGGATCAGCCAGTCGTGGAGTGGGACGCGCAGCCCG 120
17919R-3.IR_full 121 GGGAGTTCTACACGCTCATTATGACGGATCCCGATGCCCCCAGCCGAGCGGAGCCCAAGT 180
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17919R-3.in silico 121 GGGAGTTCTACACGCTCATTATGACGGATCCCGATGCCCCCAGCCGAGCGGAGCCCAAGT 180
17919R-3.IR_full 181 TCCGCGAGTTCAAGCACTGGATTCTGGCCAACATCGCCGGCAACGACTTGGCAAGTGGTG 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17919R-3.in silico 181 TCCGCGAGTTCAAGCACTGGATTCTGGCCAACATCGCCGGCAACGACTTGGCAAGTGGTG 240
17919R-3.IR_full 241 AGCCCATCGCCGAGTACATTGGCTCCGGCCCGCCCCAGGGCACGGGTCTGCATCGCTACG 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17919R-3.in silico 241 AGCCCATCGCCGAGTACATTGGCTCCGGCCCGCCCCAGGGCACGGGTCTGCATCGCTACG 300
17919R-3.IR_full 301 TCTTCCTGCTGTACAAGCAGTCCGGCAAACTTGAGTTCGACGAGGAGCGCGTGAGCAAGA 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17919R-3.in silico 301 TCTTCCTGCTGTACAAGCAGTCCGGCAAACTTGAGTTCGACGAGGAGCGCGTGAGCAAGA 360
17919R-3.IR_full 361 GATCCCGCAAGGATCGCCCCAAATTCAGTGCCGCCAAGTTTGCCATCAATCACGAGTTGG 420
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17919R-3.in silico 361 GATCCCGCAAGGATCGCCCCAAATTCAGTGCCGCCAAGTTTGCCATCAATCACGAGTTGG 420
17919R-3.IR_full 421 GCAATCCCATTGCTGGAACTTTCTACCAAGCCCAGTACGACGACTATGTTCCAAAACTGC 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17919R-3.in silico 421 GCAATCCCATTGCTGGAACTTTCTACCAAGCCCAGTACGACGACTATGTTCCAAAACTGC 480
17919R-3.IR_full 481 ACAAGCAACTTTCGGAGAA 499
|||||||||||||||||||
17919R-3.in silico 481 ACAAGCAACTTTCGGAGAA 499
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 100 |
477 |
0 |
0 |
0 |
NM_141387.2 |
CG17919-RA (CG17919), mRNA |
| 0.41 |
2 |
2 |
7 |
39 |
NM_141386.1 |
CG10298-RA (CG10298), mRNA |
| 0 |
0 |
6 |
19 |
42 |
NM_142794.1 |
CG18594-RA (CG18594), mRNA |
| 0 |
0 |
3 |
2 |
12 |
NM_001042796.1 |
CG6775-RC, transcript variant C (rg), mRNA |
| 0 |
0 |
3 |
2 |
12 |
NM_080023.1 |
CG6775-RA, transcript variant A (rg), mRNA |
| 0 |
0 |
3 |
2 |
12 |
NM_167028.1 |
CG6775-RB, transcript variant B (rg), mRNA |
| 0 |
0 |
2 |
11 |
21 |
NM_142793.2 |
CG7054-RA (CG7054), mRNA |
| 0 |
0 |
2 |
3 |
3 |
NM_135239.1 |
CG18304-RA (CG18304), mRNA |
| 0 |
0 |
2 |
3 |
2 |
NM_001038877.1 |
CG13516-RA (CG13516), mRNA |
| 0 |
0 |
2 |
3 |
2 |
NM_144288.1 |
CG12644-RA (CG12644), mRNA |
| 0 |
0 |
2 |
3 |
2 |
NM_136052.2 |
CG10383-RA (CG10383), mRNA |
| 0 |
0 |
1 |
15 |
29 |
NM_135744.1 |
CG6180-RA (CG6180), mRNA |
| 0 |
0 |
1 |
6 |
2 |
NM_166353.1 |
CG10023-RC, transcript variant C (Fak56D), mRNA |
| 0 |
0 |
1 |
6 |
2 |
NM_166352.1 |
CG10023-RB, transcript variant B (Fak56D), mRNA |
| 0 |
0 |
1 |
6 |
2 |
NM_079069.2 |
CG10023-RA, transcript variant A (Fak56D), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_176378.1 |
CG33056-RA, transcript variant A (CG33056), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_001043147.1 |
CG32178-RB, transcript variant B (Msi), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_001043148.1 |
CG32178-RC, transcript variant C (Msi), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_080281.3 |
CG32178-RA, transcript variant A (Msi), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_165560.1 |
CG1882-RB, transcript variant B (CG1882), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_165561.1 |
CG1882-RC, transcript variant C (CG1882), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_165562.1 |
CG1882-RD, transcript variant D (CG1882), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_136482.1 |
CG1882-RA, transcript variant A (CG1882), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_176381.1 |
CG33056-RE, transcript variant E (CG33056), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_176377.1 |
CG33056-RC, transcript variant C (CG33056), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_176380.1 |
CG33056-RD, transcript variant D (CG33056), mRNA |
| 0 |
0 |
1 |
3 |
4 |
NM_176379.1 |
CG33056-RB, transcript variant B (CG33056), mRNA |
| 0 |
0 |
1 |
3 |
3 |
NM_078533.1 |
CG11213-RA (Cp38), mRNA |
| 0 |
0 |
1 |
3 |
3 |
NM_132495.2 |
CG1751-RA (Spase25), mRNA |
| 0 |
0 |
1 |
2 |
5 |
NM_136732.1 |
CG12904-RA (CG12904), mRNA |
|
|
|
